Automation, Collaboration and the Future of Advanced Therapies
In this episode of Denatured, you'll listen to Jason Jones, head of global business development at Cellular Origins and Alexander Seyf, founder & CEO of Autolomous. They discuss how cell and gene therapy manufacturing is facing growing pressure to scale more quickly and efficiently, driving developers and manufacturers toward automation, digitization, robotics and broader collaboration across the ecosystem.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Jason Jones, Head of Global Business Development, Cellular Origins
Alexander Seyf, Founder & CEO, Autolomous…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.